EN
Meta title: 600 mg ALA Per Capsule or Serving? The Label Trap
Meta description: Reconcile ALA amount per capsule, serving, day, chemical form, raw-material input, fill feasibility, bottle count, and market-specific labels.
The front label shouts “ALA 600 mg.” The Supplement Facts panel defines a two-capsule serving. The factory quote is priced per capsule. The clinical paper used 600 mg per day.
Four teams see the same number and calculate four different products.
For Amazon brands, private-label buyers, and OEM formulators, 600 mg is not a formula until the unit, serving, day, chemical form, input basis, and directions are locked.
Put every amount on one line
Create a mass-balance row before selecting a bottle:
> ___ mg approved ALA material per capsule × ___ capsules per serving × ___ servings per day = ___ mg material per day, delivering ___ mg on the approved label basis.
Then add:
- ALA form: DL-ALA, R-ALA free acid, sodium R-lipoate, or another specifically approved material;
- assay and calculation basis;
- lipoic-acid equivalent where applicable;
- sodium contribution for a sodium salt;
- justified manufacturing adjustment or overage;
- excipients per unit;
- target fill weight and capsule shell.
If the team cannot complete this line, it is not ready to compare a “600 mg” competitor.
Use the ALA form and label-math worksheet before choosing the headline amount.
Per serving is not per capsule
A U.S. label in NIH's Dietary Supplement Label Database provides one real example of 600 mg ALA in a one-capsule serving. Another commercial offer may provide 600 mg across two capsules. Both can use 600 mg prominently if the presentation is accurate and compliant, but they create different:
- unit sizes;
- capsule counts;
- days of supply;
- cost per day;
- fulfillment weight;
- swallowing burden;
- consumer expectations.
Do not copy the biggest visible number from a competitor. Read serving size, directions, form, other ingredients, and count.
The chemical form changes what “600 mg” means
Health Canada's June 2025 monograph distinguishes DL-ALA and R-ALA and uses form-specific quantities in its compendial framework. It also treats sodium R-(+)-lipoate as a source preparation for R-ALA. Those Canadian details are not a universal global formula, but they show why “ALA 600 mg” cannot be separated from form and jurisdiction.
Questions for regulatory and formulation:
- Is the label declaring commercial material or an approved equivalent?
- Does the salt add sodium that must be evaluated?
- Does the proposed daily amount fit the country's product pathway?
- Does the evidence use the same form and daily regimen?
- Does “R-ALA 600 mg” accidentally double a benchmark that involved racemic material?
Read why a total ALA COA may not prove an R-ALA claim.
A 600 mg input does not guarantee a one-capsule product
Capsule capacity depends on volume, not weight alone. The ALA grade's bulk and tapped density, particle profile, flow, agglomeration, excipients, shell size, equipment, and fill-weight variation determine what can be produced.
The fill includes more than the front-label active:
- assay-adjusted ALA input;
- flow aid or lubricant;
- filler needed for process consistency;
- other active ingredients;
- formulation overage if justified;
- carrier included in a stabilized material.
Measure the commercial blend. Do not select a capsule from a generic milligram-capacity chart.
RainwoodBio publishes custom hard-capsule and ALA capsule options. Ask for a project-specific fill calculation and pilot result rather than assuming the catalog image establishes capacity.
Three honest format options
One larger capsule
This can support a simple serving if the commercial blend fits and the target buyer accepts the shell size. Verify equipment, fill variation, swallowing, and bottle dimensions.
Two smaller capsules
This can improve manufacturability and swallowing but doubles unit count for the same days of supply. The front label and directions must make the serving clear.
Tablet or alternative dosage form
A tablet may carry a different load but introduces compression, disintegration, hardness, friability, coating, and swallowing questions. A gummy or powder creates stability and sensory problems. Format changes are not free space.
Use RainwoodBio's published OEM format-development process to compare at least two manufacturable concepts before artwork.
The bottle-count trap
If 600 mg requires two capsules per day:
- 60 capsules = 30 days;
- 120 capsules = 60 days;
- a “two-month supply” claim depends on the directions remaining one serving per day.
If directions change to twice daily, the days of supply change again. Normalize competitor price by:
1. compliant daily serving;
2. days per package;
3. capsules or tablets per day;
4. active form and amount;
5. testing and packaging;
6. subscription and fulfillment cost.
A cheaper 60-count bottle may cost more per day than a larger pack.
Evidence can break even when the number matches
“600 mg” appears in many ALA studies, but study relevance depends on:
- oral versus intravenous route;
- racemic versus R form;
- free acid versus salt;
- once-daily versus divided dosing;
- participant population;
- duration;
- co-ingredients;
- outcome;
- totality and limitations.
A two-capsule supplement does not become the studied intervention because the arithmetic reaches 600.
The label approval checklist
Before artwork, confirm:
- exact ingredient name and form;
- material input per unit;
- declaration basis per serving;
- serving size and daily directions;
- sodium or other counterion impact;
- capsule size, fill weight, and pilot feasibility;
- count and days of supply;
- finished-product content method;
- stability at end of shelf life;
- claim-to-evidence match;
- destination-market warnings and required statements.
How RainwoodBio can support the 600 mg decision
RainwoodBio publishes a general ALA capsule page and OEM services. The page title and marketing statements do not prove that every custom formula contains 500 mg or 600 mg of a specified ALA form per capsule, nor that such a formula fits, is stable, or is approved for every market.
Ask RainwoodBio for:
- exact proposed ALA form and supplier specification;
- per-unit, per-serving, and per-day reconciliation;
- proposed capsule size, shell, excipients, and fill weight;
- one- versus two-capsule feasibility;
- finished assay and stability plan;
- bottle count, MOQ, price, and days-of-supply comparison;
- market and claim questions requiring regulatory approval.
Request an ALA capsule-fit and label-math review. Send RainwoodBio your target form, amount, label draft, maximum capsule count, market, evidence references, other actives, shell, pack count, volume, and target price; the team can return two manufacturable serving options.
Frequently asked questions
1.Is 600 mg the required ALA dose worldwide?
No universal supplement dose or claim rule should be assumed. The correct amount depends on form, product pathway, evidence, safety review, intended use, and destination market.
2.Can 600 mg ALA fit in one capsule?
Possibly for some materials and capsule systems, but only a measured blend and production trial can establish feasibility.
3.Can we label sodium R-lipoate as 600 mg R-ALA?
Do not assume so. Reconcile the salt input, assay, equivalent, sodium, ingredient naming, and market rules.
4.Does a 600 mg study prove our 600 mg product?
Not without matching form, route, regimen, population, duration, matrix, outcome, and claim.
References
- Health Canada DL-Alpha-Lipoic Acid/R-Alpha-Lipoic Acid monograph: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_alpha-lipoic-acid_english.pdf
- NIH Dietary Supplement Label Database, ALA 600 mg example: https://dsld.od.nih.gov/label/332407
- USP Alpha Lipoic Acid: https://doi.usp.org/USPNF/USPNF_M45550_04_01.html
- RainwoodBio alpha lipoic acid capsules: https://www.rainwoodbio.com/oem-odm-alpha-lipoic-acid-capsules-500mg-high-quality-alpha-lipoic-acid-capsules
- RainwoodBio custom hard capsules: https://www.rainwoodbio.com/custom-hard-capsules
*This article is for international B2B formulation and educational purposes. ALA form, amount, equivalent, serving, capsule feasibility, finished testing, stability, labels, claims, directions, and regulatory requirements must be confirmed for the exact formula, product, and destination market.*